Evidence map›Paper›PMID 37762298›Full record

ArticleInternational journal of molecular sciences2023

Dynamic Interplay in Tumor Ecosystems: Communication between Hepatoma Cells and Fibroblasts.

Gábor Petővári, Gábor Tóth, Lilla Turiák, Anna L Kiss, Krisztina Pálóczi, Anna Sebestyén, Adrián Pesti, András Kiss, Kornélia Baghy, Katalin Dezső and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. The logarithmic phase as a therapeutic direction: evaluating pharmacological strategies against cancer progression.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Gábor PetőváriDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Üllői út 26, H-1085 Budapest, Hungary.
Gábor TóthMS Proteomics Research Group, Research Centre for Natural Sciences, Eötvös Loránd Research Network, Magyar Tudósok Körútja 2, H-1117 Budapest, Hungary.ORCID 0000-0003-1428-7906
Lilla TuriákMS Proteomics Research Group, Research Centre for Natural Sciences, Eötvös Loránd Research Network, Magyar Tudósok Körútja 2, H-1117 Budapest, Hungary.ORCID 0000-0002-2139-8156
Anna L KissDepartment of Human Morphology and Developmental Biology, Semmelweis University, Tűzoltó u. 58, H-1094 Budapest, Hungary.
Krisztina PálócziDepartment of Genetics, Cell and Immunobiology, Semmelweis University, H-1085 Budapest, Hungary.
Anna SebestyénDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Üllői út 26, H-1085 Budapest, Hungary.
Adrián PestiDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Üllői út 93, H-1091 Budapest, Hungary.ORCID 0000-0001-6706-6221
András KissDepartment of Pathology, Forensic and Insurance Medicine, Semmelweis University, Üllői út 93, H-1091 Budapest, Hungary.
Kornélia BaghyDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Üllői út 26, H-1085 Budapest, Hungary.ORCID 0000-0002-5323-2775
Katalin DezsőDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Üllői út 26, H-1085 Budapest, Hungary.
Tibor FüleThermo Fisher Scientific Inc., Váci út. 41-43, H-1134 Budapest, Hungary.
Péter TátraiCharles River Laboratories Hungary, Irinyi József utca 4-20, H-1117 Budapest, Hungary.ORCID 0000-0001-9726-1992
Ilona KovalszkyDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Üllői út 26, H-1085 Budapest, Hungary.ORCID 0000-0002-0179-3378
Andrea ReszegiDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Üllői út 26, H-1085 Budapest, Hungary.
Semmelweis University · HUResearch Network (United States) · US

Funding

Hungarian Scientific Research Fund 100904 and 119283 to I.K.Hungarian Scientific Research Fund 131603 to L.THungarian Scientific Research Fund 138593 to K.B.Hungarian Scientific Research Fund FK-138763 to K.D.Hungarian Scientific Research Fund K-128881 to A.K.Hungarian Scientific Research Fund K-142799 to A.S.Hungarian Scientific Research Fund PD-142418 to G.P.National Research, Development and Innovation Fund, New National Excel-lence Program of the Ministry of Human Capacities ÚNKP-22-4-II-SE-9 to G.P.Semmelweis Scientific and Innovation Fund STIA-KFI-2022 to A.R.
6 · The paper itself

Abstract

Tumors are intricate ecosystems where cancer cells and non-malignant stromal cells, including cancer-associated fibroblasts (CAFs), engage in complex communication. In this study, we investigated the interaction between poorly (HLE) and well-differentiated (HuH7) hepatoma cells and LX2 fibroblasts. We explored various communication channels, including soluble factors, metabolites, extracellular vesicles (EVs), and miRNAs. Co-culture with HLE cells induced LX2 to produce higher levels of laminin β1, type IV collagen, and CD44, with pronounced syndecan-1 shedding. Conversely, in HuH7/LX2 co-culture, fibronectin, thrombospondin-1, type IV collagen, and cell surface syndecan-1 were dominant matrix components. Integrins α6β4 and α6β1 were upregulated in HLE, while α5β1 and αVβ1 were increased in HuH7. HLE-stimulated LX2 produced excess MMP-2 and 9, whereas HuH7-stimulated LX2 produced excess MMP-1. LX2 activated MAPK and Wnt signaling in hepatoma cells, and conversely, hepatoma-derived EVs upregulated MAPK and Wnt in LX2 cells. LX2-derived EVs induced over tenfold upregulation of SPOCK1/testican-1 in hepatoma EV cargo. We also identified liver cancer-specific miRNAs in hepatoma EVs, with potential implications for early diagnosis. In summary, our study reveals tumor type-dependent communication between hepatoma cells and fibroblasts, shedding light on potential implications for tumor progression. However, the clinical relevance of liver cancer-specific miRNAs requires further investigation.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsCollagen Type IVCommunicationEcosystemFibroblastsHumansProteoglycansSyndecan-1Collagen Type IVProteoglycansSPOCK1 protein, humanSyndecan-1cell communicationextracellular vesiclefibroblasthepatoma cellinvasionmetabolismmiRNAstromatumor

Identifiers

PMID37762298
PMCPMC10530979
OpenAlexW4386647953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.